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Purpose:Neurofibromatosis type I (NF-I) is an autosomal dominant disorder affecting one in 3000 individuals. Vascular
abnormalities are a well-recognized manifestation of NF-I. The purpose of this study is to review the spectrum,
management, and clinical outcome of patients with vascular abnormalities and NF-I.
Methods: We retrospectively reviewed 31 patients (15 males, 16 females) with clinical NF-I and vascular abnormalities
identified from imaging or operative findings between 1976 and 2005.
Results: The diagnosis of NF-I was made at a mean age of 11  10 years with vascular lesions identified at a mean age of
38  16 years. There were 76 vascular abnormalities, including 38 aneurysms, 20 arterial stenoses, 5 arteriovenous
malformations (AVM), 5 arteries compressed or invaded by neural tumors, and 6 abnormalities of the heart valves.
Arterial lesions were located in the aorta (n  17) and in the renal (n  12), mesenteric (n  12), carotid-vertebral (n 
10), intracerebral (n  4), and subclavian-axillary and iliofemoral arteries (3 each). Interventions were required in 23
patients (74%); 15 underwent 24 arterial reconstructions, including 9 renal, 8 aortic, 4 mesenteric, 2 carotid, and 1
femoral. The other eight patients had excision of AVM in three, vessel ligation in two, and clipping of cerebral aneurysms,
coil embolization of hepatic aneurysms, and left thoracotomy in one patient each. One patient died of ruptured
abdominal aortic aneurysm. Six patients (26%) had postoperative complications, including pneumonia in two, and stroke,
acalculous cholecystitis, brachial plexopathy and chylothorax in one patient each. The median follow up was 4.1 years
(range, 6 months to 20 years). Late vascular problems developed in three patients, including graft stenoses in two and
rupture of another aortic aneurysm in one. Freedom from graft-related complications was 83% at 10 years. Patient
survival at 10 years was 77%, less than the 86% expected survival for the general population (P < .001).
Conclusion: Patients with NF-I have a wide spectrum of vascular abnormalities, most notably aneurysms or stenoses of the
aortic, renal, and mesenteric circulation. Operative treatment of symptomatic patients with vascular lesions or large
aneurysms is safe, effective, and durable. ( J Vasc Surg 2007;46:475-84.)Neurofibromatosis type I (NF-I), or von Reckling-
hausen disease, is an autosomal dominant disorder affecting
one in 3000 individuals.1 Cardinal features of NF-I include
multiple café au lait macules, benign neurofibromas, and
iris hamartomas.1 Other common manifestations are learn-
ing disabilities, short stature, and skeletal abnormalities.
Vascular lesions of medium and large-sized arteries and
veins are a well-recognized, albeit rare, feature.2,3 The term
NF-I vasculopathy has been coined in the medical literature
to describe aneurysms, stenoses, and arteriovenous malfor-
mations occurring in patients with NF-I.3,4 The pathogen-
esis, clinical spectrum, and natural history of these abnor-
malities are unknown.
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doi:10.1016/j.jvs.2007.03.055Most patients with NF-I vascular abnormalities are
asymptomatic but have involvement of multiple vessels.2-4
Symptoms usually occur in childhood or early adult-
hood.2-4 The renal artery is the most frequent site of
involvement, and renovascular hypertension is the most
common presentation.2-4 Abdominal aortic coarctation,
internal carotid artery aneurysms, and cervical vertebral
arteriovenous malformations are other common manifesta-
tions.2-4 The purpose of this study was to review the
spectrum, management, and clinical outcome of patients
with NF-I vascular abnormalities. In addition, a review of
the English-language literature is summarized.
METHODS
We identified 31 patients with NF-I and vascular ab-
normalities from the vascular surgery and medical genetics
registries who were evaluated at the Mayo Clinic in Roch-
ester, Minnesota, between January 1, 1976, and January 1,
2005. Clinical diagnosis of NF-I wasmade from at least two
of seven diagnostic criteria, as defined by the National
Institutes of Health (NIH) consensus statement: six or
more café au lait macules, two or more neurofibromas,
axillary freckling, two or more Lisch nodules (iris hamarto-
mas), sphenoid dysplasia or thinning of long bone cortex,
or a first-degree relative diagnosed with NF-I.1
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eurysms, stenoses, arteriovenous malformations (AVM),
and arterial compression or invasion by neural tumor. In
general, criteria for operative or interventional treatment
were presence of symptoms, rupture, or large aneurysm
size. We used the same standard size recommendations (eg,
abdominal aortic aneurysm, 5.5 cm) used for repair of
aneurysms in patients without neurofibromatosis. Vascular
lesions that were asymptomatic and aneurysms of small
diameter were observed. Follow-up usually included annual
physical examination and repeat imaging.
The pathologic specimens and radiologic studies were
reviewed whenever possible. The medical records were
reviewed for patient demographics, clinical characteristics,
cardiovascular risk factors, operative data, and early and late
morbidity and mortality. Late follow-up data were ob-
tained frommedical records, correspondence with referring
physicians, telephone interviews, and from a detailed ques-
tionnaire sent to each patient. The National Death Index
Search was used to document late mortality data, if needed.
Survival curves were calculated using the Kaplan-Meier
method and compared with the expected survival for age-
matched and sex-matched controls from the State of Min-
nesota. Data was presented as median values or mean 
standard deviation, as appropriate. A value of P  .05 was
significant. The study was approved by the Mayo Founda-
tion Institutional Review Board.
RESULTS
Clinical characteristics. There were 15 male and 16
female patients with a mean age of 11  10 years (range,
1 to 40 years) at time of NF-I diagnosis. The clinical
diagnostic criteria and associated pathologic features are
summarized in Table I. Café au lait macules and neurofi-
bromas were most common, occurring in 94% of patients
each, followed by inguinal or axillary freckling, or both, in
65%, and Lisch nodules in 42%. Positive family history was
present in 15 patients (48%). Cardiovascular risk factors
included hypertension in 16 patients (52%), cigarette
smoking in 8 (26%), chronic renal insufficiency in 3 (10%),
and hyperlipidemia, coronary artery disease, cerebrovascu-
lar disease, and chronic obstructive pulmonary disease in 2
patients each (6%).
Diagnostic investigation. Thirty patients (97%) un-
derwent 75 radiologic studies. The abdominal vessels were
imaged in 18 patients (60%), thoracic in 15 (50%), cervical
in 14 (47%), and cerebral in 10 (33%). Contrast arteriog-
raphy (Fig 1, A and B) was done in 23 patients (77%), 18
(60%) had computed tomography, 13 (42%) had magnetic
resonance imaging, and 8 (26%) had ultrasound imaging.
An echocardiogram was obtained in 11 patients (37%).
Vascular abnormalities. Seventy-six vascular abnor-
malities were identified in 31 patients (Table II). The first
abnormality was diagnosed at an average age of 38  16
years (range, 3 to 77 years). Forty lesions carried symptoms
and 37 did not. Vascular abnormalities included 40 aneu-
rysms in 18 patients, 20 arterial stenoses in 7, 5 AVM in 5
patients, and 5 arteries compressed or invaded by neuraltumors in 4 patients. These lesions were found most often
in the aortic (n 17), renal (n 12), mesenteric (n 12),
and carotid-vertebral circulations (n  10). Five patients
had six heart valve abnormalities, including mitral valve and
aortic valve regurgitation in two patients each, and mitral
valve prolapse and aortic valve stenosis in one patient each.
Pathologic findings. Eight patients had 16 pathologic
specimens reviewed. Five patients (age, 3 to 32 years) had
four renal, two mesenteric, and two supraceliac aortic spec-
imens reviewed. The histology in this group showed vascu-
lar dysplasia without evidence of atherosclerosis. Specific
findings were fibromuscular dysplasia with neointimal
thickening in all renal lesions (Fig 1, C), proliferation of
Schwann cells and fibroblasts associated with plexiform
neurofibroma and fibromuscular dysplasia of small vessels,
and false aneurysm associated with neointimal thickening in
the supraceliac aortic aneurysm. A 73-year-old patient with
a giant thrombosed true internal jugular vein aneurysm had
stretched disrupted elastic fibers and thick organizing gran-
ulation tissue consistent with low-grade inflammatory re-
sponse on microscopy.
The two other patients, age 77 and 74 years, were
treated for abdominal aortic aneurysms. One patient died
from ruptured aneurysm and at autopsy was found to have
five other asymptomatic aneurysms involving both internal
carotid, both vertebral, and the basilar arteries. The seven
arterial specimens from these two patients showed athero-
sclerotic changes without vascular dysplasia.
Operative treatment. A total of 41 vascular abnormali-
ties (Table II and III) were repaired in 23 patients (74%).
Indications included renovascular hypertension in 7 patients,
large aneurysm size or rupture in 6, pain in 4,malignancy in 2,
Table I. National Institutes of Health diagnostic
criteria* in 31 patients with vascular abnormalities
associated with neurofibromatosis syndrome type I
Clinical features Patients (n) Percent
NIH diagnostic criteria
Café au lait macules 29 94
Neurofibromas 29 94
Inguinal or axillary freckling 20 65
First-degree relative with NF-I 15 48
Lisch nodules 13 42
Sphenoid bone dysplasia 2 6
Cortical long bone thinning 2 6
Associated pathology
Scoliosis 5 16
Pseudoarthrosis 4 13
Malignant tumor degeneration 2 6
Optic nerve glioma 1 3
Pheochromocytoma 1 3
Gray matter ectopia 1 3
Mental retardation 1 3
Hydrocephalus 1 3
NIH, National Institutes of Health; NF-1, neurofibromatosis.
*National Institutes of Health (NIH) consensus conference statement,
1988.and chronic mesenteric ischemia, disabling claudication, sub-
ery.
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venous malformation in 1 patient each.
One or more arterial reconstructions were done in 15
patients. Six patients required 9 aortorenal artery bypasses,
4 with polyester, 3 with saphenous vein, and 2 with internal
iliac artery. Eight patients had aortic reconstructions, which
consisted of 4 aortoaortic grafts, 2 abdominal patch aorto-
plasties (Fig 1, D), 1 aortobiiliac, and 1 aortobifemoral
graft. Three patients needed four mesenteric reconstruc-
tions, including three aorta-superior mesenteric artery by-
passes and 1 celiac patch angioplasty. Femoral-femoral,
carotid-carotid, and carotid-axillary artery bypass was done
in 1 patient each. The interventions in the remaining eight
patients included excision of a symptomatic AVM in three,
and 1 patient each had primary ligation of a left subclavian
artery, excision of a giant thrombosed internal jugular vein
Fig 1. A, Abdominal aortogram and selective renal angi
renal artery stenoses and a large left renal artery aneurysm
predominance of neointimal thickening (arrow). D, Th
findings and the operative treatment with a longitudinal a
Superior mesenteric artery; IMA, inferior mesenteric artaneurysm, clipping of multiple cerebral aneurysms, coilembolization of multiple hepatic aneurysms, and resuscita-
tive left thoracotomy.
One intraoperative death from ruptured abdominal
aortic aneurysm occurred among the 23 patients who re-
quired interventions. Intraoperative bleeding requiring
transfusion occurred in two patients because of increased
vascular fragility. One patient had a giant internal jugular
vein aneurysm and the other had a 5-cm left subclavian
artery aneurysm. In both cases, multiple pledgeted sutures
were required to obtain hemostasis. Six patients (26%)
presented with postoperative complications, including pul-
monary problems in two, and a large middle cerebral terri-
tory stroke, acute acalculous cholecystitis, brachial plexopa-
thy, and chylothorax in one each. Themedian length of stay
was 8 days (range, 3 to 105 days).
Conservative treatment. Seventeen asymptomatic pa-
hy reveals abdominal aortic coarctation B, with bilateral
enal artery specimen shows fibromuscular dysplasia with
ist’s illustration summarizes preoperative angiographic
inal aortoplasty and bilateral renal artery bypasses. SMA,ograp
.C, R
e art
bdomtients with 35 vascular abnormalities were treated conser-
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small for repair. Another two aneurysms in the cavernous
and supra-clinoid portion of the internal carotid artery were
observed because of difficult access for repair. Follow-up
included annual physical examination and radiologic imag-
ing at 6-month to 18-month intervals, depending on the
size and location of the aneurysms.
Late outcome. The 30 survivors were followed up for
a median of 4.1 years (range, 6 months to 19.7 years).
Repeat imaging studies were done in 21 patients (70%).
Twenty-seven patients were asymptomatic and did not
develop any late vascular problem. All patients with reno-
vascular hypertension were either cured or had improved
blood pressure control on smaller doses of antihypertensive
medications. One patient who was treated conservatively
for an ascending aortic aneurysm died of ruptured aneu-
Table II. Distribution of 76 vascular abnormalities in 31
Location
Vascular abnormalities
Lesions (n) Patients (n
Aneurysms 40 18
Internal carotid artery 6 4
Cerebral 4 3
Ascending aorta 4 4
Abdominal aorta 5 5
Renal artery 3 3
Vertebral artery 3 2
Descending thoracic aorta* 2 2
Hepatic artery 2 1
Internal jugular vein 2 1
TAA aorta 1 1
Common iliac artery 3 2
Subclavian artery 1 1
Axillary artery 1 1
Gastroduodenal artery 1 1
Pancreaticoduodenal artery 1 1
Lumbar artery 1 1
Stenoses 20 7
Renal artery 9 6
Abdominal aortic coarctation 4 4
Celiac artery 3 3
Superior mesenteric artery 3 3
TAA coarctation 1 1
Arteriovenous malformations 5 5
Extremity 2 2
Thoracic vertebral 1 1
Cervical vertebral 1 1
Facial 1 1
Arterial compression 3 2
Subclavian 1 1
Celiac axis 1 1
Superior mesenteric artery 1 1
Tumor invasion 2 2
Superficial femoral artery 1 1
Common carotid artery 1 1
Heart valves 6 5
Total† 76 31
TAA, Thoracoabdominal aortic.
*One patient had a descending thoracic aneurysm repaired elsewhere.
†Several patients had multiple vascular lesions.rysm 2.6 years later.Survival free of secondary vascular or graft-related
complications in 21 patients with repeat imaging study
was 90% at 1 year (Greenwood standard deviation
[GSD], 6.6%) and 83% at 10 years (GSD, 9.4%). Overall,
secondary complications developed in three (20%) of 15
patients who had arterial reconstructions. A 72-year-old
woman with multiple comorbidities died of a ruptured
ascending aortic aneurysm 2.6-years after repair of a
descending thoracic aneurysm. A 32-year-old man
treated for chronic mesenteric ischemia with a bypass
from the aorta to the superior mesenteric artery devel-
oped graft thrombosis 20-months after operation. A
bypass from the aorta to the common hepatic artery was
performed, and he is asymptomatic 19 years later. A
33-year-old woman who had bilateral aorta-to-renal sa-
phenous vein grafts presented with recurrent renal artery
nts with neurofibromatosis type I
Treatment
Operative Conservative
Lesions (n) Patients (n) Lesions (n) Patients (n)
19 12 21 15
1 1 5 3
1 1 3 2
0 0 4 4
5 5 0 0
2 2 1 1
0 0 3 2
2 2 0 0
2 1 0 0
1 1 1 1
0 0 1 1
2 1 1 1
1 1 0 0
0 0 1 1
1 1 0 0
1 1 0 0
0 0 1 1
15 7 5 2
9 6 0 0
3 3 1 1
1 1 2 2
1 1 2 2
1 1 0 0
3 3 2 2
1 1 1 1
0 0 1 1
1 1 0 0
1 1 0 0
3 2 0 0
1 1 0 0
1 1 0 0
1 1 0 0
2 2 0 0
1 1 0 0
1 1 0 0
0 5 6 5
41 23 35 17patie
)stenosis at both sites 16 months postoperatively. She
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and a bovine patch angioplasty of the right distal anas-
tomosis. The right aorta-to-renal graft occluded 6
months after the revision and she needed a right ne-
phrectomy. The aorta-to-left renal artery bypass is patent
14 years after the operation, and her hypertension re-
mains well controlled.
Overall patient survival at 10 years was 77% (GSD,
6.8%), less than the 87% expected for an age-matched and
sex-matched population of the State of Minnesota (P 
.001, Fig 2). Six patients (20%) died during follow-up, four
from malignancy, one from ruptured ascending aortic an-
eurysm, and one from an unknown cause. Two of the
malignancies were neurofibrosarcoma.
DISCUSSION
Neurofibromatosis type I is an autosomal dominant
disorder resulting from a mutation of the NF-I gene lo-
cated on the long arm of chromosome 17 (17q11.2).2-4
Although the NF-I gene mutation has nearly complete
penetrance and will cause some clinical manifestations by
adulthood, its expressions are highly variable. The protein
product of the gene, neurofibromin, shares sequence and
functional homology with the ras oncogene, a tumor sup-
pressor gene. Therefore, loss of neurofibromin produces
increased mitogenic signaling and leads to increased cellu-
lar proliferation or differentiation. For this reason, the NF-I
gene mutation is associated with multiple neoplasms, most
commonly malignant nerve sheath tumors, myelogenous
leukemia, pheochromocytoma, and neurofibromas.2-5
Intrinsic lesions of the arterial wall are important man-
ifestations of NF-I, yet the pathogenesis of these lesions
remains ill defined. Reubi6 first classified the vascular his-
tology into intimal, aneurysmal or fusocellular forms. A
common finding between the types is spindle cell prolifer-
ation. Other authors believe that the vascular lesions de-
velop either by proliferation of nerves within the vessel walls
or from compression or invasion by neural tumors.3 This
latter theory does not correlate well with clinical findings,
however. More often, the histologic feature is fibromuscu-
lar dysplasia with a predominance of intimal thickening.4
It may be that arterial stenoses or aneurysms in these
patients occur by a dynamic process of cellular prolifera-
tion, degeneration, healing, smooth muscle loss, and fibro-
sis. Moreover, neurofibromin expression has been demon-
strated in the vascular endothelial and smooth muscle cells.
This suggests that deficiency in neurofibromin in NF-I may
cause proliferation within the vessel wall, a process analo-
gous to that which produces multiple cutaneous neurofi-
bromas.3
The term NF-I vasculopathy has been used by medical
geneticists to describe the vascular lesions in NF-I.3-4 The
frequency of this vasculopathy is hard to define because
screening studies are not routinely done, but the prevalence
of vascular lesions in large clinical series is 0.4% to 6.4%.2-4
Lin et al2 found a 2% prevalence of cardiovascular abnor-
malities among 2322 participants in the National Neurofi-
bromatosis Foundation database. Only 16 patients (0.7%)had peripheral artery abnormalities, including nine (0.4%)
with renal artery stenoses. These numbers likely underesti-
mate the true prevalence of these lesions because radiologic
studies are reserved for symptomatic patients or in those
suspected of having a vascular abnormality.
We found vascular lesions in NF-I patients aged 50
years to differ in type, location, and histology compared
with older patients. We identified a predominance of aortic,
renal, mesenteric, and carotid-vertebral stenoses or aneu-
rysms in the younger patients, whereas the older ones had
degenerative atherosclerotic aortic aneurysms. Although
atherosclerosis typically involves the origin or bifurcation of
large arteries, NF-I vascular lesions often do not. For
example, the renal and mesenteric arterial lesions in our
patients were often long and tapered and extended into the
primary branches of the artery but spared its aortic origin.
Aortic aneurysms involved the ascending or thoracoab-
dominal aorta more often than the infrarenal segment.
Furthermore, the histologic specimens from younger pa-
tients showed fibromuscular dysplasia or spindle cell prolif-
eration in striking contrast to the degenerative atheroscle-
rotic changes in older patients. The reasons why lesions
develop in some patients at a young age and in others at an
older age, and how NF-I impacts the development of
atherosclerosis, are unclear.
A review of the English-language literature from 1957
to 2005 yielded 237 patients with NF-I who had 320
vascular abnormalities, including the 31 patients reported
here.2,7-40 Renal artery lesions are most common (41%),
are unilateral in 68%, and are more often stenotic than
aneurysmal. Renal artery disease was diagnosed between
the ages of 11 and 21 years (Table IV). Renal artery
aneurysms are often intrarenal, which precludes arterial
reconstruction in some patients. The carotid, vertebral, or
cerebral artery lesions seen in 19% of patients are commonly
aneurysms, occur in the third decade of life, and occurmore
often in women (72%). Abdominal aortic coarctation or
aneurysms, with or without renal and mesenteric involve-
ment, have been reported in 12%.
Treatment depends on the patient’s age and the type and
location of the lesion. Isolated renal artery disease has been
treated with open or endovascular techniques, nephrectomy,
or medical therapy (Table V, online only).7-23 Open renal
artery reconstruction has been done in 45 of the 97 reported
cases, the plurality done with an autologous aortorenal artery
bypass. Hypertension was cured or improved in 38 patients
(84%), but recurrent stenosis developed in seven (15%). Per-
cutaneous transluminal angioplasty was used to treat 21 le-
sions in 18 patients, but eight (44%) presented with restenosis
requiring another intervention. Medical therapy alone was
used in 18 patients, but six failed therapy. Nephrectomy was
the sole treatment in 16 patients. Given these data, our pref-
erence is to perform open reconstruction with an aortorenal
artery autologous bypass.
The aorta may be aneurysmal or stenotic. Aneurysms
predominate in patients aged 50, whereas abdominal
aortic coarctation occurs more often in younger pa-
tients.13,20-24 In our opinion, the indications for treatment
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type I
Patient
Age,
sex
No. NIH
criteria
Cardiovascular
abnormalities
Clinical
presentation Treatment Early outcome Late outcome*
Conservative treatment
1 18M 2 R forearm AVM Conservative Asymptomatic, 15 yr FU
2 72M 5 R common iliac artery
aneurysm, MVR
Asymptomatic Conservative Asymptomatic, 4.5 yr FU
3 20F 4 Ascending aortic
aneurysm, AVR
Asymptomatic Conservative Asymptomatic, 4.3 yr FU
4 50F 5 Bilateral internal
carotid artery
aneurysms
Asymptomatic Conservative Asymptomatic, 14 yr FU
5 75M 2 Ascending aortic and
TAAs, MVR and
AVR
Asymptomatic Conservative Died: cholangiocarcinoma,
18 mon FU
6 20F 3 R internal carotid
artery aneurysm
Asymptomatic Conservative Asymptomatic, 11 mon
FU
7 21M 4 R RAA Asymptomatic Conservative Died: NF-I– related
cancer, 12 yr FU
8 7M 4 Thoracolumbar spine
AVM
Asymptomatic Conservative Asymptomatic,16 yr FU
Operative treatment
9 6F 3 Abdominal aortic
coarctation,
bilateral RA
stenoses
Renovascular
hypertension
Abdominal aortoplasty,
bilateral RA bypass
No comp Improved BP control, 3 yr
FU
10 9M 2 Abdominal aortic
coarctation, right
RA and SMA
stenoses
Renovascular
hypertension
Supra-celiac to infra-
RA bypass, aorto-RA
and aorta-SMA
bypass
No comp Cured BP, 8 mon FU
11 17M 3 Abdominal aortic
coarctation,
bilateral RA
stenoses, and L
RAA
Renovascular
hypertension
Abdominal aortoplasty,
bilateral RA bypass
No comp BP cured at 11.5 years FU
12 3F 4 R RA, celiac and SMA
stenoses
Renovascular
hypertension
Aorto-RA bypass No comp BP improved, 14 yr FU
13 33F 2 Bilateral RA stenoses Renovascular
hypertension
Bilateral aorto-RA
bypass
No comp Recurrent L RA stenosis,
R RA occlusion at 16
mon FU; redo L RA
bypass, R nephrectomy.
BP improved, 14 yr FU
14 26M 3 Mild aortic stenosis,
celiac, and SMA
stenoses, L RA
occlusion with large
RAA, and multiple
lumbar artery
aneurysms
Renovascular
hypertension
Resection of RAA and
aorto-RA bypass
No comp BP cured, 5.6 yr FU
15 22F 4 TAA coarctation,
supraceliac aortic
saccular aneurysm,
occluded celiac axis
Renovascular
hypertension
Descending thoracic to
pararenal aortic
bypass, aorto-SMA
bypass
No comp BP cured, 4 years FU
16 77M 2 AAA Large size Aortoaortic graft No comp Asymptomatic, 5 yr FU
17 73F 3 R internal jugular vein
aneurysm, L
internal jugular vein
ectasia
Large size R internal jugular vein
ligation
Vascular
fragility,
intra-op
pulmonary
embolism
Asymptomatic, 22 mon
FU
18 43F 3 Prior ruptured TAA,
5-cm L subclavian
aneurysm, and
vertebral and
middle cerebral
Large size L subclavian artery
ligation, carotid-
subclavian artery
bypass
Brachial
plexopathy,
vascular
fragility,
bleeding
Asymptomatic, 7.5 yr FUartery aneurysms
p, no
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without NF-I. In general, we offer repair of abdominal
aortic aneurysms 5.5 cm in diameter, and thoracoab-
dominal aneurysms 6.0 cm, depending on the patient’s
age and comorbidities.
Although there are no reports of endovascular repair
for aneurysms associated with NF-I, this approach could
be applied to select older patients. We noted no fragility
Table III. Continued.
Patient
Age,
sex
No. NIH
criteria
Cardiovascular
abnormalities
Clinical
presentatio
19 72F 5 Ascending aortic and
descending TAA,
AVS
Large size
20 68M 5 Ascending aortic,
axillary, AAA, and
bilateral common
iliac artery
aneurysms
Large size
21 74M 2 Ruptured AAA;
bilateral internal
carotid and
vertebral and basilar
artery aneurysms
Pain
22 16F 4 Large facial AVM Bleeding
23 32M 3 Celiac and superior
mesenteric artery
occlusion
Chronic
mesenteri
ischemia
24 71M 4 AAA with aortoiliac
occlusive disease,
MVP
Disabling
claudicati
25 21M 3 L subclavian artery
stenosis
Pain
26 12F 3 Multiple (4)
gastroduodenal and
hepatic artery
aneurysms
Pain
27 41F 5 L lower extremity
AVM
Pain
28 28F 3 Cervical vertebral
artery AVM
Pain
29 32F 5 R femoral artery
stenoses due to
tumor invasion
Malignancy
30 44M 2 Tumor invasion of R
common carotid
artery
Malignancy
31 43F 2 R internal carotid,
middle cerebral and
temporal artery
aneurysms
Subarachno
hemorrha
NIH, National Institutes of Health;AAA, abdominal aortic aneurysm;AVM
aneurysmMVR,mitral valve regurgitation; TAA, thoracoabdominal aortic a
valve stenosis; SMA, superior mesenteric artery; BP, blood pressure; No com
*Patients were alive at follow-up, unless indicated otherwise.of the aorta or abdominal branch arteries during openrepair, but two patients with aneurysms, one jugular vein
and the other subclavian artery, had friable vessels.
Therefore, some precautionary measures are appropriate.
We recommend gentle, atraumatic, and delicate han-
dling of tissues, careful placement of retractors, and use
of soft, protected arterial clamps. We are unaware of any
reports showing increased risk of complications with
diagnostic angiography and other catheter-based proce-
Treatment Early outcome Late outcome*
Aortoaortic graft No comp Died: ruptured
ascending AA,
2.6 yr FU
Aortobiiliac bypass Pneumonia Died: unknown
cause, 4 mon
FU
Left thoracotomy for
resuscitation
Intra-op death
Total excision No comp Asymptomatic,
4.3 yr FU
Aorto-SMA bypass,
celiac axis patch
angioplasty
No comp Occluded graft,
20 mon FU;
redo
aortohepatic
artery bypass;
asymptomatic,
19 yr FU
Aortobifemoral bypass No comp Asymptomatic,6
yr FU
L subclavian artery
ligation, resection of
neurofibroma
Chylothorax
treated
conservatively
Asymptomatic at
20 mon FU
Coil embolization Acute acalculous
cholecystitis,
cholecystectomy
Asymptomatic,
10.6 yr FU
Partial excision No comp Asymptomatic, 6
mon FU
R vertebral artery
ligation, resection of
AVM
No comp Asymptomatic, 5
yrs FU
Wide local excision,
femoral artery
interposition graft
No comp Died: tumor
recurrence, 3.5
yr FU
Wide local excision,
carotid artery
interposition graft
No comp Died: tumor
recurrence, 6
mon FU
Clipping of R internal
carotid and middle
cerebral artery
aneurysms
R hemispheric
stroke
Permanent
deficit, 2 yr FU
iovenous malformation; FU, follow-up;RA, renal artery;RAA, renal artery
m,AVR, aortic valve regurgitation;MVP,mitral valve prolapse;AVS, aortic
complications; NF-1, neurofibromatosis type I.n
c
on
id
ge
, arter
neurysdures in NF-I patients.
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inal aortic coarctation who have renovascular hypertension
unresponsive to medical therapy, chronic mesenteric ische-
mia, disabling claudication, or combinations thereof. The
Fig 2. Kaplan-Meier estimates of overall survival for patients with
neurofibromatosis-1 (NF-I, solid line) are compared with age-
matched and sex-matched controls of the general population of the
State of Minnesota (MN, dashed line).
Table IV. Summary of case reports and literature reviews
neurofibromatosis type I
Type and location of vascular lesion Reference
P
Isolated renal artery disease 7-22
Unilateral
Bilateral
Stenosis
Aneurysm
Isolated mesenteric artery disease 23
Stenosis
Aneurysm
Abdominal/distal thoracic coarctation 13, 20-24
Associated renal disease
Associated mesenteric disease
Aortic aneurysm or dissection 25-27
Ascending aorta
Descending aorta
Thoracoabdominal aorta
Abdominal aorta
Carotid, vertebral and cerebral aneurysms 28-32
Internal carotid artery aneurysm
Vertebral artery aneurysm
Cerebral artery aneurysm
Subclavian or innominate artery disease 33-35
Aneurysm/dissection/rupture
Stenoses
Axillary, brachial, radial artery aneurysm 36
Arteriovenous malformations 37-38
Cervical vertebral
Lumbar spinal
Trunk/extremity
Facial
Other miscellaneous lesions 39-40
Infrainguinal artery aneurysm
Internal jugular vein aneurysm
Totalaorta is frequently narrowed in the paravisceral segment,although we, and others, have reported distal thoracic
involvement.20-24 Supraceliac-to-infrarenal aortic bypass or
patch aortoplasty are the treatment options. We favor a
midline, transperitoneal approach with medial visceral ro-
tation in most patients, or a low left thoracoabdominal
approach if the distal thoracic aorta is involved. A
supraceliac-to-infrarenal aorta bypass with end-to-side
anastomoses is preferred for patients with a long (5 to 6
cm) narrowed aortic segment. This technique minimizes
renal andmesenteric ischemia time and allows placement of
a larger graft in children whose aorta will still grow. Addi-
tional grafts to the renal and mesenteric arteries are done as
needed. Abdominal aortoplasty is reserved for patients with
a focal narrowing of the aorta but may be used in conjunc-
tion with aortic bypass in cases of long segment stenosis.
Other manifestations of NF-I vasculopathy deserve
comment. From the literature review, carotid, vertebral,
and cerebral aneurysms, reported in 46 patients, occur in
the third decade of life and are more frequent in women
(72%). Cervical vertebral AVM are a classic presentation
and may be the late result of contained ruptured vertebral
artery aneurysms. Spontaneous subclavian artery rupture,
ported cases of vascular abnormalities in patients with
s Lesions
(n)
Mean age
(yr) Range Male/Female
129 12.5 0.4-46 46M/51 F
65 12.5 2-34 31M/34 F
64 10.5 0.4-46 15M/17 F
117 11.2 0.4-34 42M/44 F
12 21.4 6-46 4M/7 F
11 36.5 12-55 1M/4 F
2 32 12 M
9 37.2 14-55 0M/4 F
52 11.2 1.3-26 9M/8 F
25 11.8 1.3-26 9M/7 F
8 15.1 11-26 3M/3 F
14 59.5 20-77 6M/3 F
4 43 20-74 2M/2 F
4 64 45-75 2M/2 F
1 75 30 M
4 73 68-77 4M/0 F
54 34.7 1-60 13M/33 F
26 29.3 1-60 5M/17 F
13 44.8 0.5-59 2M/10 F
15 30.1 7-60 6M/6 F
15 38.1 9-61 4M/11 F
13 45.8 32-61 3M/10 F
2 15 9-21 1M/1 F
4 40.6 30-74 3M/1 F
32 35.8 11-60 6M/26 F
22 38.1 11-60 3M/19 F
2 8.5 7 and 10 1M/1 F
5 39.3 18-59 1M/4 F
3 34 16-58 1M/2 F
9 52.1 11-73 1M/7 F
6 39.1 11-72 1M/5 F
3 67.5 62 and 73 0M/2 F
320 25.6 0.4-77 85M/134 Fof re
atient
(n)
97
65
32
86
11
5
1
4
17
16
6
13
4
4
1
4
46
22
12
12
15
13
2
4
32
22
2
5
3
8
6
2upper and lower extremity aneurysms, and AVM of the
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Our patient with the giant internal jugular vein aneurysm is
the second one to be reported in the literature.40
Survival is shorter in patients with NF-I compared with
the general population.5 An analysis of United States death
certificates shows that patients with NF-I die at a median
age of 59 years, 15 years younger than controls matched for
age and sex.5 The most common cause of death is malig-
nancy, often from connective and soft-tissue neoplasms.
Vascular disease is the second leading cause of death, espe-
cially among those individuals aged 40 years old.5 Our
outcome data are similar.
The role of routine vascular screening has not been
evaluated. Because clinically significant lesions are relatively
uncommon (2%), periodic vascular assessment cannot be
recommended to all NF-I patients. Instead, we currently
advocate selective imaging if there is clinical suspicion. If a
vascular abnormality is identified on initial screening study
(eg, renal ultrasound imaging for hypertension), nonin-
vasive imaging (computed tomography angiography or
magnetic resonance angiography) of the head, chest, and
abdomen is justifiable because of the multiplicity of
lesions in some patients. In our opinion, recommenda-
tions for follow-up study should be the same as for
patients without NF-I.
CONCLUSION
Patients with NF-I have a wide spectrum of vascular
lesions. Aneurysms or stenoses of the aortic, renal, and
mesenteric arteries are the most common lesions. Most
lesions occur by age 50 years and are due to an underlying
vasculopathy. Operative treatment of patients with symp-
tomatic disease or large aneurysms is safe, effective, and
durable.
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concomitant renal and/or mesenteric artery disease in pati
Type of lesion Reference Patients (n)
Renal artery disease 7-22
Open arterial reconstruction 45
Autologous 27
Prosthetic 7
Not specified 11
Percutaneous angioplasty 18
Nephrectomy 16
Medical therapy 18
Abdominal aortic coarctation 13, 20-24
Aortoplasty/bypass 17
FU, Follow-up.nal artery lesions and abdominal aortic coarctation with
ents with neurofibromatosis type I
Lesions (n) Mean FU Cured/Improved Worse/Recurred
67 47  65 38 7
38 44  58 25 2
11 28  27 4 3
18 87  80 9 2
21 27  29 10 8
16 25  58 13 3
25 11  20 12 6
52 56  62 13 4
